Current Ratio of Apellis Pharmaceuticals, Inc. from 30 Jun 2018 to 31 Dec 2025
- Taxonomy & unit
- ratio: x
- Description
- The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
- Summary
-
Apellis Pharmaceuticals, Inc. quarterly Current Ratio in x history and change rate from 30 Jun 2018 to 31 Dec 2025.
- Apellis Pharmaceuticals, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 3.55x, a 18% decline year-over-year.
Current Ratio, Quarterly (x)
Current Ratio, YoY Quarterly Change (%)
Apellis Pharmaceuticals, Inc. Quarterly Current Ratio (x)
| Period | Value | YoY Chg | Change % | Date |
|---|---|---|---|---|
| Q4 2025 | 3.55x | -0.78x | -18% | 31 Dec 2025 |
| Q3 2025 | 3.87x | -0.11x | -2.7% | 30 Sep 2025 |
| Q2 2025 | 4.11x | +0.15x | +3.9% | 30 Jun 2025 |
| Q1 2025 | 4.43x | +0.46x | +12% | 31 Mar 2025 |
| Q4 2024 | 4.33x | -0.24x | -5.2% | 31 Dec 2024 |
| Q3 2024 | 3.97x | -1.07x | -21% | 30 Sep 2024 |
| Q2 2024 | 3.96x | -1.74x | -31% | 30 Jun 2024 |
| Q1 2024 | 3.97x | -2.35x | -37% | 31 Mar 2024 |
| Q4 2023 | 4.57x | -2.2x | -32% | 31 Dec 2023 |
| Q3 2023 | 5.04x | -2.41x | -32% | 30 Sep 2023 |
| Q2 2023 | 5.7x | -1.34x | -19% | 30 Jun 2023 |
| Q1 2023 | 6.32x | +0.31x | +5.1% | 31 Mar 2023 |
| Q4 2022 | 6.76x | +0.93x | +16% | 31 Dec 2022 |
| Q3 2022 | 7.46x | +1.38x | +23% | 30 Sep 2022 |
| Q2 2022 | 7.04x | +0.1x | +1.5% | 30 Jun 2022 |
| Q1 2022 | 6.01x | -3.51x | -37% | 31 Mar 2022 |
| Q4 2021 | 5.84x | -4.36x | -43% | 31 Dec 2021 |
| Q3 2021 | 6.08x | -4.5x | -43% | 30 Sep 2021 |
| Q2 2021 | 6.94x | -3.79x | -35% | 30 Jun 2021 |
| Q1 2021 | 9.52x | +0.34x | +3.7% | 31 Mar 2021 |
| Q4 2020 | 10.2x | +1.52x | +18% | 31 Dec 2020 |
| Q3 2020 | 10.58x | -0.25x | -2.3% | 30 Sep 2020 |
| Q2 2020 | 10.73x | -1.18x | -9.9% | 30 Jun 2020 |
| Q1 2020 | 9.18x | -6.81x | -43% | 31 Mar 2020 |
| Q4 2019 | 8.68x | -8.54x | -50% | 31 Dec 2019 |
| Q3 2019 | 10.82x | -10.37x | -49% | 30 Sep 2019 |
| Q2 2019 | 11.91x | -8.41x | -41% | 30 Jun 2019 |
| Q1 2019 | 15.99x | 31 Mar 2019 | ||
| Q4 2018 | 17.21x | 31 Dec 2018 | ||
| Q3 2018 | 21.2x | 30 Sep 2018 | ||
| Q2 2018 | 20.32x | 30 Jun 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.